Elaine O'Hara - Mar 1, 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
EVP, Chief Strategy Officer
Signature
/s/ Mark J. Casey, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Mar 1, 2024
Transactions value $
$76,673
Form type
4
Date filed
3/5/2024, 07:30 PM
Previous filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $106K +19.6K $5.39 19.6K Mar 1, 2024 Direct
transaction NVAX Common Stock Tax liability -$29K -5.38K -27.42% $5.39 14.2K Mar 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -19.6K -33.33% $0.00 39.2K Mar 1, 2024 Common Stock 19.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F2 The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.